• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高度致敏患者的移植:挑战与建议。

Transplantation in highly sensitized patients: challenges and recommendations.

机构信息

a Department of Immunohematology and Blood Transfusion , Leiden University Medical Center , Leiden , the Netherlands.

出版信息

Expert Rev Clin Immunol. 2018 Aug;14(8):673-679. doi: 10.1080/1744666X.2018.1498335. Epub 2018 Jul 13.

DOI:10.1080/1744666X.2018.1498335
PMID:30004800
Abstract

Highly sensitized patients awaiting a kidney transplant accrue on the transplant waiting list. The breadth of HLA antibodies in this subpopulation of patients precludes receiving a compatible organ offer through regular allocation within an acceptable time-frame. Areas covered: Several alternative options to receive a transplant exist for these patients, including additional priority in regular allocation, special programs based on allocation through acceptable antigens, kidney paired donation programs, desensitization protocols, or a combination of the latter two. In this review, these options and their outcomes are discussed as well as some possibilities to further enhance transplantation of this disadvantaged group of patients. Expert commentary: For highly sensitized patients, special attention is required, for which several strategies may apply. A step-wise approach may be the optimal strategy to facilitate successful transplantation of highly sensitized patients.

摘要

高度致敏的患者在等待肾移植时会被列入移植等待名单。该亚群患者的 HLA 抗体种类繁多,使得他们无法在可接受的时间内通过常规分配获得匹配的器官。 涵盖领域:对于这些患者,存在几种替代的移植选择,包括在常规分配中获得额外的优先权、基于可接受抗原进行分配的特殊计划、配对肾脏捐赠计划、脱敏方案,或后两者的组合。在这篇综述中,讨论了这些选择及其结果,以及进一步增强这个处于不利地位的患者群体移植的一些可能性。 专家评论:对于高度致敏的患者,需要特别关注,为此可能有几种策略可供选择。分阶段的方法可能是促进高度致敏患者成功移植的最佳策略。

相似文献

1
Transplantation in highly sensitized patients: challenges and recommendations.高度致敏患者的移植:挑战与建议。
Expert Rev Clin Immunol. 2018 Aug;14(8):673-679. doi: 10.1080/1744666X.2018.1498335. Epub 2018 Jul 13.
2
Highly Sensitized Patients Are Well Served by Receiving a Compatible Organ Offer Based on Acceptable Mismatches.高致敏患者通过接受基于可接受错配的相容器官供体获益良好。
Front Immunol. 2021 Jun 25;12:687254. doi: 10.3389/fimmu.2021.687254. eCollection 2021.
3
Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.基于已证实可接受抗原的肾脏分配可导致高度致敏患者的移植物存活率更高。
Kidney Int. 2018 Feb;93(2):491-500. doi: 10.1016/j.kint.2017.07.018. Epub 2017 Sep 22.
4
Transplantation of the broadly sensitized patient: what are the options?广泛致敏患者的移植:有哪些选择?
Curr Opin Organ Transplant. 2011 Dec;16(6):588-93. doi: 10.1097/MOT.0b013e32834c23ba.
5
Extending options for highly sensitized patients to receive a suitable kidney graft.为高敏患者提供更多选择,使其能够接受合适的肾移植。
Curr Opin Immunol. 2005 Oct;17(5):536-40. doi: 10.1016/j.coi.2005.07.010.
6
How the definition of acceptable antigens and epitope analysis can facilitate transplantation of highly sensitized patients with excellent long-term graft survival.可接受抗原的定义和表位分析如何能够促进高度致敏患者的移植并实现优异的长期移植物存活。
Curr Opin Organ Transplant. 2018 Aug;23(4):493-499. doi: 10.1097/MOT.0000000000000545.
7
Transplantation of highly sensitized patients via the acceptable mismatch program or desensitization? We need both.通过可接受错配方案或脱敏治疗对高敏患者进行移植?两者我们都需要。
Curr Opin Organ Transplant. 2009 Aug;14(4):410-3. doi: 10.1097/MOT.0b013e32832c433f.
8
European Guideline for the Management of Kidney Transplant Patients With HLA Antibodies: By the European Society for Organ Transplantation Working Group.欧洲器官移植学会工作组:《HLA 抗体阳性肾移植受者管理的欧洲指南》。
Transpl Int. 2022 Aug 10;35:10511. doi: 10.3389/ti.2022.10511. eCollection 2022.
9
Does the Canadian allocation system for highly sensitized patients work?加拿大高度致敏患者的分配系统是否有效?
Curr Opin Organ Transplant. 2019 Jun;24(3):239-244. doi: 10.1097/MOT.0000000000000635.
10
A Europe wide acceptable mismatch program will enable transplantation of long waiting highly sensitised patients with a compatible donor.一个全欧洲可接受的不匹配计划将使等待已久的高度致敏患者能够与相容的供体进行移植。
Transpl Immunol. 2021 Feb;64:101354. doi: 10.1016/j.trim.2020.101354. Epub 2020 Dec 1.

引用本文的文献

1
Diverse potential of chimeric antigen receptor-engineered cell therapy: Beyond cancer.嵌合抗原受体工程细胞疗法的多样潜力:超越癌症。
Clin Transl Med. 2025 Apr;15(4):e70306. doi: 10.1002/ctm2.70306.
2
Anti-HLA Class II Antibodies Are the Most Resistant to Desensitization in Crossmatch-positive Living-donor Kidney Transplantations: A Patient Series.抗HLA II类抗体在交叉配型阳性的活体供肾移植中对脱敏治疗最具抗性:病例系列研究
Transplant Direct. 2024 Aug 29;10(9):e1695. doi: 10.1097/TXD.0000000000001695. eCollection 2024 Sep.
3
European Consensus on the Management of Sensitized Kidney Transplant Recipients: A Delphi Study.
欧洲共识:致敏肾移植受者的管理:一项 Delphi 研究。
Transpl Int. 2024 Apr 11;37:12475. doi: 10.3389/ti.2024.12475. eCollection 2024.
4
Immunoadsorption-Based HLA Desensitization in Patients Awaiting Deceased Donor Kidney Transplantation: An Interventional, Non-Randomised, Single Cohort Study.免疫吸附法 HLA 脱敏在等待尸体供肾移植患者中的应用:一项介入性、非随机、单队列研究。
Transpl Int. 2023 Aug 23;36:11212. doi: 10.3389/ti.2023.11212. eCollection 2023.
5
Sex and Gender Disparities in Living Kidney Donation: A Scoping Review.活体肾移植中的性别差异:一项范围综述。
Transplant Direct. 2023 Aug 24;9(9):e1530. doi: 10.1097/TXD.0000000000001530. eCollection 2023 Sep.
6
Differences between Very Highly Sensitized Kidney Transplant Recipients as Identified by Machine Learning Consensus Clustering.基于机器学习共识聚类分析的超高敏肾移植受者差异。
Medicina (Kaunas). 2023 May 18;59(5):977. doi: 10.3390/medicina59050977.
7
Novel insights in the clinical management of hyperimmune patients before and after transplantation.移植前后超免疫患者临床管理的新见解。
Curr Res Immunol. 2023 Jan 23;4:100056. doi: 10.1016/j.crimmu.2023.100056. eCollection 2023.
8
Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation.嵌合抗原受体(CAR)调节性 T 细胞在实体器官移植中的应用。
Front Immunol. 2022 May 26;13:874157. doi: 10.3389/fimmu.2022.874157. eCollection 2022.
9
Desensitization using IVIG alone for living-donor kidney transplant: impact on donor-specific antibodies.单独使用 IVIG 进行脱敏治疗对活体供肾移植的影响:供体特异性抗体。
J Bras Nefrol. 2022 Oct-Dec;44(4):527-532. doi: 10.1590/2175-8239-JBN-2021-0200.
10
Highly Sensitized Patients Are Well Served by Receiving a Compatible Organ Offer Based on Acceptable Mismatches.高致敏患者通过接受基于可接受错配的相容器官供体获益良好。
Front Immunol. 2021 Jun 25;12:687254. doi: 10.3389/fimmu.2021.687254. eCollection 2021.